Sequence 3

DRUG5 trials

Sponsors

Yuhan Corporation, University of Colorado, Denver, Chong Kun Dang Pharmaceutical, Centre Hospitalier Universitaire Dijon, JHM BioPharma (Tonghua) Co. , Ltd.

Conditions

DyslipidemiasHealthyHypertensionMild Cognitive DisorderUpper Limb SpasticityWillpower

Phase 1

Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

CompletedNCT01332890

Yuhan CorporationHealthy

Start: 2011-04-30End: 2011-08-31Updated: 2014-07-10

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2018-08-31End: 2019-01-15Target: 30Updated: 2018-11-01

A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity

CompletedNCT06584240

JHM BioPharma (Tonghua) Co. , Ltd.Upper Limb Spasticity

Start: 2024-09-14End: 2025-07-23Updated: 2025-09-02

Unknown Phase

A Pilot Study: Snacking, Willpower and Glucose Availability

CompletedNCT02258477

University of Colorado, DenverWillpower

Start: 2014-10-31End: 2015-02-28Updated: 2016-03-04

Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.

RecruitingNCT04754906

Centre Hospitalier Universitaire DijonMild Cognitive Disorder

Start: 2021-01-25End: 2028-12-31Target: 684Updated: 2025-09-22